Listing 1 - 2 of 2 |
Sort by
|
Choose an application
"This volume addresses current emerging concepts in the field of angiogenesis, including important angiogenesis modifiers which are essential in combination with growth factors (VEGF and FGF) for the physiological process and also for therapeutic applications. It covers many of the lesser discussed areas including blood vessel growth guidance (interactions with CNS) as well as emerging practical applications of these concepts. The book comprises in-depth reviews by leading experts in several major areas: recent basic science discoveries about angiogenesis modifiers (semaphorins, ephrins and nitric oxide, for which the Nobel Prize was awarded); arterial guidance; clinical applications of new angiogenic factors (HGF, HIF and eNOS); and basic and clinical advancement of anti-angiogenic molecules for the treatment of cancer and macular degeneration (tyrosine kinase inhibitors and NO). These topics, especially their unique combination presented in this volume, are not found in any other current books on angiogenesis. This makes the book a must-read for readers both interested and actively involved in the most recent advances in basic principles and clinical applications of angiogenesis."
Neovascularization. --- Vascular endothelial growth factors. --- Vascular endothelial growth factors --- Neovascularization inhibitors. --- Angiogenesis inhibitors --- Tumor angiogenesis inhibitors --- Antineoplastic agents --- Angiogenic factors --- Angiogenic proteins --- Endothelial growth factors, Vascular --- VEGFs (Proteins) --- Growth factors --- Blood-vessels --- Therapeutic use. --- Growth
Choose an application
Blood-vessels --- Vascular Endothelial Growth Factors --- Angiogenesis Modulating Agents --- Clinical Trials as Topic --- Neoplasms --- Neovascularization, Pathologic --- Neovascularization, Physiologic --- Growth --- therapeutic use --- pathology --- Vascular Endothelial Growth Factors. --- Clinical Trials as Topic. --- Neovascularization, Pathologic. --- Neovascularization, Physiologic. --- Clinical Trial as Topic --- Clinical Protocols --- Drug Evaluation --- Drugs, Investigational --- Clinical Trials Data Monitoring Committees --- Therapies, Investigational --- VEGFs --- Angiogenesis, Physiological --- Neovascularization, Physiological --- Physiologic Angiogenesis --- Physiologic Neovascularization --- Angiogenesis, Physiologic --- Physiological Angiogenesis --- Physiological Neovascularization --- Collateral Circulation --- Vascular Remodeling --- Angiogenesis, Pathological --- Neovascularization, Pathological --- Pathologic Angiogenesis --- Pathologic Neovascularization --- Angiogenesis, Pathologic --- Pathological Angiogenesis --- Pathological Neovascularization --- therapeutic use. --- pathology. --- Angiogenesis --- Blood-vessels - Growth --- Angiogenesis Modulating Agents - therapeutic use --- Neoplasms - pathology --- VASCULAR ENDOTHELIAL GROWTH FACTORS --- ANGIOGENESIS MODULATING AGENTS --- CLINICAL TRIALS --- NEOPLASMS --- NEOVASCULARIZATION, PATHOLOGIC --- NEOVASCULARIZATION, PHYSIOLOGIC --- THERAPEUTIC USE --- PATHOLOGY
Listing 1 - 2 of 2 |
Sort by
|